Corrigendum to “Liquiritigenin is a plant-derived highly selective estrogen receptor β agonist” [Mol. Cell. Endocrinol. 283 (2008) 49–57]

a Departments of Obstetrics, Gynecology and Reproductive Sciences and Center for Reproductive Sciences, Cellular and Molecular Pharmacology, University of California, San Francisco, CA, United States b Bionovo Inc., Emeryville, CA, United States c Departments of Urology, Pathology and Laboratory Medicine, and James P. Wilmot Cancer Center, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States d Department of Nutritional Sciences and Toxicology, University of California, Berkeley, CA, United States